Bliss GVS Pharma Limited
Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.
What Bliss files
- Others85
- Important26
- Board Meeting16
- QIP/Rights/Pref.11
- Updates9
- Dividend/Bonus6
Anupam Rasayan's open offer for a 26% stake (2.77 Cr shares) in Bliss GVS Pharma now includes Mates Visa Consultancy as a Person Acting in Concert.
Bliss GVS Pharma Limited has informed the Exchange about Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Bliss GVS Pharma's manufacturing facility has achieved WHO-GMP compliance, confirming high quality and operational excellence. This key development enhances market access and product credibility, reflecting strong standards.
Bliss GVS Pharma's Independent Director, Mr. Santosh Parab, has concluded his second and final term, stepping down from the board. This changes the company's governance structure.
Anupam Rasayan announced an open offer to acquire 26% of Bliss GVS Pharma for up to ₹829.03 Cr at ₹299/share. This follows a pact to buy a 43.30% stake for ₹1,369.51 Cr, leading to a change of control.